Daily choices of functional foods supplemented with milled flaxseed by a patient population over one year

Journal of Functional Foods

Volumn 26, Issue , 2016, Pages 772-780

  Austria, J Alejandro ^a   Aliani, Michel ^a   Malcolmson, Linda J ^b   Dibrov, Elena ^a   Blackwood, David P ^a   Maddaford, Thane G ^a   Guzman, Randy ^a   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Canadian International Grains Institute   (Canada)

Author keywords

Cardiovascular disease; Dietary supplementation; Flaxseed; Food; Linseed; Nutrition

Indexed keywords

EID: 84986563375     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.08.045     Document Type: Article

References (20)

1. Aliani, M., Ryland, D., Pierce, G.N., Effect of flax addition on the flavor profile of muffins and snack bars. Food Research International 44 (2011), 2489–2496.
2. Aliani, M., Ryland, D., Pierce, G.N., Effect of flax addition on the flavor profile and acceptability of bagels. Journal of Food Science 71 (2012), S62–S79.
3. Ander, B.P., Weber, A.R., Rampersad, P., Gilchrist, J.S.C., Pierce, G.N., Lukas, A., Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic rabbits. The Journal of Nutrition 134 (2004), 3250–3256.
4. Austria, J.A., Richard, M.N., Chahine, M.N., Edel, A.L., Malcolmson, L.J., Dupasquier, C.M.C., Pierce, G.N., Bioavailability of alpha linolenic acid in subjects after ingestion of three different forms of flaxseed. Journal of the American College of Nutrition 27 (2008), 214–221.
5. Bassett, C.M.C., McCullough, R.S., Edel, A.L., Patenaude, A., La Vallee, R., Pierce, G.N., The alpha linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. American Journal of Physiology. Heart and Circulatory Physiology 301 (2011), H2220–H2226.
6. Bassett, C.M.C., Rodriguez-Leyva, D., Pierce, G.N., Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition et Métabolisme 34 (2009), 965–974.
7. Caligiuri, S.P.B., Aukema, H.M., Ravandi, A., Guzman, R., Dibrov, E., Pierce, G.N., Flaxseed consumption reduces blood pressure in hypertensive patients by altering circulating oxylipins via an alpha linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension 64 (2014), 53–59b.
8. Caligiuri, S.P.B., Aukema, H., Ravandi, A., Pierce, G.N., Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption. Experimental Gerontology 59 (2014), 51–57a.
9. Caligiuri, S.P.B., Edel, A.L., Aliani, M., Pierce, G.N., Flaxseed for hypertension: implications for blood pressure regulation. Current Hypertension Reports 16 (2014), 499–512c.
10. Caligiuri, S.P.B., Penner, B., Pierce, G.N., The HYPERFlax trial: determining the anti-HYPERtensive effects of dietary Flaxseed in newly diagnosed Stage 1 hypertensive patients – a Phase II randomized double-blinded clinical trial. Trials, 15, 2014, 232d.
11. Dodin, S., Lemay, A., Jacques, H., Legare, F., Forest, J.C., Masse, B., The effects of flaxseed dietary supplement in lipid profile, bone mineral density and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. Journal of Clinical Endocrinology Metabolism 90 (2005), 1390–1397.
12. Dupasquier, C.M.C., Dibrov, E., Kneesh, A.L., Cheung, P.K.M., Lee, K.G.Y., Alexander, H.K., Yeganeh, B., Moghadasian, M.H., Pierce, G.N., Dietary flaxseed inhibits atherosclerosis in the LDL receptor deficient mouse in part through anti-proliferative and anti-inflammatory actions. American Journal of Physiology. Heart and Circulatory Physiology 293 (2007), H2394–H2402.
13. Dupasquier, C.M.C., Weber, A.-M., Ander, B.P., Rampersad, P.P., Steigerwald, S., Wigle, J.T., Mitchell, R.W., Kroeger, E.A., Gilchrist, J.S.C., Moghadasian, M.M., Lukas, A., Pierce, G.N., The effects of dietary flaxseed on vascular contractile function and atherosclerosis in rabbits during prolonged hypercholesterolemia. American Journal of Physiology. Heart and Circulatory Physiology 291 (2006), H2987–H2996.
14. Edel, A.L., Rodriguez-Leyva, D., Maddaford, T.G., Caligiuri, S.P.B., Austria, J.A., Weighell, W., Guzman, R., Aliani, M., Pierce, G.N., Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral arterial disease. The Journal of Nutrition 145 (2015), 749–757.
15. Francis, A.A., Austria, J.A., La Vallee, R.K., Deniset, J.F., Maddaford, G.G., Dibrov, E., Pierce, G.N., The effects of dietary flaxseed on atherosclerotic plaque regression. American Journal of Physiology, Heart Circulation Physiology 304 (2013), H1743–H1751.
16. Moghadasian, M.H., Eskin, N.A.M., Preface. Moghadasian, M.H., Eskin, N.A.M., (eds.) Functional foods and cardiovascular disease, 2012, CRC Press, Boca Raton, v.
17. Patenaude, A., Rodriguez-Leyva, D., Edel, A.L., Dibrov, E., Dupasquier, C.M.C., Austria, J.A., Richard, M.N., Chahine, M.N., Malcolmson, L.J., Pierce, G.N., Bioavailability of alpha linolenic acid from flaxseed diets as a function of the age of the subject. European Journal of Clinical Nutrition 63 (2009), 1123–1129.
18. Rodriguez-Leyva, D., Dupasquier, C.M.C., McCullough, R., Pierce, G.N., The omega-3 fatty acid alpha linolenic acid within flaxseed provides beneficial cardiovascular effects. Canadian Journal of Cardiology 26 (2010), 489–496.
19. Rodriguez-Leyva, D., Weighell, W., Edel, A.L., La Vallee, R., Dibrov, E., Pinneker, R., Maddaford, T.G., Ramjiawan, B., Aliani, M., Guzman, R., Pierce, G.N., Potent anti-hypertensive action of dietary flaxseed in hypertensive patients. Hypertension 62 (2013), 1081–1089.
20. Rodriguez-Leyva, D., Zahradka, P., Ramjiawan, B., Guzman, R., Aliani, M., Pierce, G.N., The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral arterial disease: the rationale and design of the FlaxPAD randomized controlled trial. Contemporary Clinical Trials 32 (2011), 724–730.